Group A streptococcal (GAS) serology is used for the diagnosis of post-streptococcal diseases, such as acute rheumatic fever, and occasionally for the diagnosis of streptococcal pharyngitis. Experts recommend that the upper limits of normal for streptococcal serology be determined for individual populations because of differences in the epidemiology of GAS between populations. Therefore, we performed a study to determine the values of the upper limit of normal for anti-streptolysin O (ASO) and anti-DNase B (ADB) titers in Fiji. Participants with a history of GAS disease, including pharyngitis or impetigo, were excluded. A total of 424 serum samples from people of all ages (with a sample enriched for school-aged children) were tested for their ASO and ADB titers. Reference values, including titers that were 80% of the upper limit of normal, were obtained by regression analysis by use of a curve-fitting method instead of the traditional nonparametric approach. Normal values for both the ASO titer and the ADB titer rose sharply during early childhood and then declined gradually with age. The estimated titers that were 80% of the upper limit or normal at age 10 years were 276 IU/ml for ASO and 499 IU/ml for ADB. Data from our study are similar to those found in countries with temperate climates, suggesting that a uniform upper limit of normal for streptococcal serology may be able to be applied globally.Streptococcal antibody tests are used for the diagnosis of antecedent infections caused by the group A streptococcus (GAS) and are particularly useful for the diagnosis of acute rheumatic fever and acute post-streptococcal glomerulonephritis. Acute rheumatic fever is an autoimmune disease that follows infection with GAS; however, the isolation of GAS is uncommon (Ͻ15%), and so confirmation of the diagnosis often relies on streptococcal antibody tests (13). While a number of tests utilize different antigens of GAS, the most frequently performed tests are those that determine the anti-streptolysin O (ASO) titer and the anti-DNase B (ADB) titer (8,18). Ideally, it is recommended that the titer be determined in the acute phase and then determined in the convalescent phase 14 to 28 days later, with a positive result defined as a rise in titer of twofold or more (26). However, it is not always practicable to obtain a second sample for titer determination, particularly in developing countries, where acute rheumatic fever is the most common. Therefore, it is generally accepted that if only a single specimen is available, a titer greater than the upper limit of normal at the initial testing can be considered presumptive evidence of a preceding streptococcal infection (10, 12, 26).The upper limit of normal for streptococcal serology has been defined by separating the upper 20% from the lower 80% of the group distribution in a dichotomous fashion (4,12,26). The choice of the 80th centile cutoff rather than more traditional upper-limit-of-normal calculations (e.g., 2 standard deviations from the mean) is based upon studies that ...